Skip To Content

ACD/Labs Blog

Revvity Signals’ planned acquisition of ACD/Labs brings together two leading scientific software portfolios, promising deeper integration, expanded workflows, and enhanced data, automation, and analytical capabilities to better support chemistry, pharmaceutical R&D, and end-to-end scientific decision-making.